Activated AMPK shifts cells into an energy-efficient mode enhancing glucose uptake, fatty-acid oxidation, and mitochondrial respiration while downregulating fat storage and gluconeogenesis [2]
Most patients continue treatment for several months to a year, depending on their progress and goals with some patients continuing to safely use their medication for multiple years
Eligible patients lost an average of 13.6% of their body weight (-31.3 pounds) in a 64week clinical trial evaluating 25 mg oral semaglutide compared to those on 2.4mg injectable semaglutide who lost an average of 14.9% (-33.6 pounds) in a 68week clinical trial
Individual results vary based on dose, adherence, diet, and health history
Customized Treatment Plan Based on your body and goals, we create a tailored dosing schedule using Semaglutide or Tirzepatide, along with guidance to support safe and effective progress